Skip to Main Content

Paper Details

Medication-Attributable Adverse Events in Heart Failure Trials.
JACC Heart Fail
2
2023
GDMT, HFrEF, Heart Failure, Patients, angiotensin II receptor, angiotensin receptor, angiotensin-converting enzyme, glucose, heart failure, heart failure with, mineralocorticoid receptor, neprilysin, participants, patients, sodium, sodium glucose cotransporter
Author NameAffiliation
Gregg C FonarowDavid Geffen School of Medicine, University of California, Los Angeles Medical Center
Gregg C FonarowDavid Geffen School of Medicine, University of California, Los Angeles Medical Center
Adrian F HernandezDuke Clinical Research Institute, Duke University Hospital
Gary Michael FelkerDuke Clinical Research Institute, Duke University Hospital
  • 1 - 4

Datasets

Release 1.2